The landscape of cancer treatment is constantly evolving, with a growing spotlight on identifying novel therapeutic targets for drug synthesis. Traditional therapies often target rapidly dividing cells, leading to significant side outcomes. However, the emergence of sophisticated genomic profiling techniques has altered our perception of cancer bio